Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD-RSV: RSVpreF in HIV-Exposed Pregnancies
NCT07693166Phase 4Not yet recruiting
- Sponsor
- University of British Columbia
- Start
- Sep 2026
- Primary completion
- Sep 2027
01
Overview
A Phase 4 trial of RSVpreF vaccine in respiratory syncytial virus infection (RSV), sponsored by University of British Columbia. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
RSVpreF vaccine
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07693166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693166.